ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
17.896,50
-0,14%
S&P 500
5.064,20
0,91%
Dow Jones
38.225,66
0,85%
Euro vs US Dollar
1,07289
0,10%
Bitcoin
59.287,11
1,80%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Y mAbs Therapeutics Inc (YMAB)

  7. Y mAbs Therapeutics Inc (YMAB) News

YMAB Y mAbs Therapeutics Inc

17,25
0,76 (4,61%)
Nach Börsenschluss
Zuletzt aktualisiert: 23:30:00
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Y mAbs Therapeutics Inc YMAB NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,76 4,61% 17,25 23:30:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
16,49 16,295 17,39 17,25 16,49
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
26.4.202413:05GLOBEY-mAbs to Announce First Quarter 2024 Financial and..
25.4.202422:05GLOBEY-mAbs to Present at 2024 ASCO Annual Meeting
14.3.202414:05GLOBEY-mAbs Therapeutics Announces Resignation of Chief Financial..
07.3.202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202422:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202422:49EDGAR2Form 144 - Report of proposed sale of securities
06.3.202422:40EDGAR2Form 144 - Report of proposed sale of securities
06.3.202401:05EDGAR2Form 144 - Report of proposed sale of securities
04.3.202413:30GLOBEY-mAbs Appoints Oncology Executive Mary Tagliaferri, M.D. to..
04.3.202412:05EDGAR2Form 8-K - Current report
29.2.202423:04EDGAR2Form S-8 - Securities to be offered to employees in employee..
29.2.202422:05GLOBEY-mAbs Reports Fourth Quarter and Full Year 2023 Financial..
29.2.202422:04EDGAR2Form 8-K - Current report
16.2.202413:30GLOBEY-mAbs to Announce Fourth Quarter and Full Year 2023..
14.2.202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202421:59EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
23.1.202400:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.1.202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.1.202423:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.1.202423:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.1.202423:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.1.202423:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.1.202423:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.1.202412:45EDGAR2Form 8-K - Current report
02.1.202422:05GLOBEY-mAbs Therapeutics to Present at 42nd Annual J.P. Morgan..
26.12.202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.12.202301:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.12.202322:40EDGAR2Form 144 - Report of proposed sale of securities
13.12.202322:05GLOBEY-mAbs Therapeutics Added to the NASDAQ Biotechnology Index
12.12.202314:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.12.202314:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.12.202323:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.12.202323:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.12.202323:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.12.202323:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.11.202323:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.11.202323:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.11.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.11.202322:07EDGAR2Form 144 - Report of proposed sale of securities
13.11.202322:47EDGAR2Form 8-K - Current report
13.11.202322:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13.11.202322:05GLOBEY-mAbs Reports Third Quarter 2023 Financial Results and..
08.11.202323:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.11.202323:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.11.202323:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
31.10.202312:05GLOBEY-mAbs to Announce Third Quarter 2023 Financial and..
18.10.202322:09EDGAR2Form 8-K - Current report
18.10.202322:05GLOBEY-mAbs Names Michael Rossi as President and Chief Executive..
18.10.202315:00EDGAR2Form 8-K - Current report

Kürzlich von Ihnen besucht

NASDAQ
YMAB
Y mAbs Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten